# Relationship Between Central Sensitization Symptoms and Cognitive Dysfunction in Fibromyalgia

> **NCT06948903** · — · RECRUITING · sponsor: **Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey** · enrollment: 100 (estimated)

## Conditions studied

- Fibromyalgia
- Cognitive Dysfunction
- Central Sensitisation

## Interventions

- **DIAGNOSTIC_TEST:** Central Sensitization Inventory
- **DIAGNOSTIC_TEST:** The Montreal Cognitive Assessment
- **DIAGNOSTIC_TEST:** Cognitive Symptom Severity Scale-Extended
- **OTHER:** Fibromyalgia Impact Questionnaire
- **OTHER:** Numeric rating scale
- **OTHER:** Hospital Anxiety and Depression Scale

## Key facts

- **NCT ID:** NCT06948903
- **Lead sponsor:** Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-01-10
- **Primary completion:** 2025-08-01
- **Final completion:** 2025-10-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-09-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06948903

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06948903, "Relationship Between Central Sensitization Symptoms and Cognitive Dysfunction in Fibromyalgia". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06948903. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*